Examples of 'pancreatic adenocarcinoma' in a sentence
Meaning of "pancreatic adenocarcinoma"
Pancreatic adenocarcinoma: This phrase is a medical term referring to a type of cancer that originates in the pancreas, specifically affecting the cells that line the ducts of the pancreas
How to use "pancreatic adenocarcinoma" in a sentence
Basic
Advanced
pancreatic adenocarcinoma
Dose adjustments during treatment of pancreatic adenocarcinoma.
Pancreatic adenocarcinoma Abraxane administered in combination with gemcitabine.
Aberrantly expressed mature miRNAs in pancreatic adenocarcinoma.
Pancreatic adenocarcinoma is the fourth leading cause of cancer-related death and have extremely poor prognosis.
These are generally less aggressive than pancreatic adenocarcinoma.
Neuroendocrine tumors and pancreatic adenocarcinoma and desmoid tumors are examples.
Neuroendocrine pancreatic cancers behave and are treated differently than pancreatic adenocarcinoma.
It continued to be unremarkable for pancreatic adenocarcinoma and metastatic disease.
The main purpose in the study was to find new prognostic markers for pancreatic adenocarcinoma.
In one embodiment, the pancreatic adenocarcinoma is unresectable.
Further research should study further purification and other biological behaviors of pancreatic adenocarcinoma stem cells.
Pancreatic adenocarcinoma ( Pazenir administered in combination with gemcitabine ).
NovoTTF Therapy is not approved for the treatment of pancreatic adenocarcinoma or ovarian cancer.
Human pancreatic adenocarcinoma cells ( NP-9 ) were inoculated subcutaneously in immune deficient mice ( nude ).
A method according to claim 1, wherein the disorder is pancreatic adenocarcinoma.
See also
At least 50 % of people with pancreatic adenocarcinoma have diabetes at the time of diagnosis.
Thus, preferably, pancreatic cancer as used herein is pancreatic adenocarcinoma.
Inhibition by mAb W9 of human pancreatic adenocarcinoma MIAPaCa-2 cancer initiating cell in vitro proliferation.
Clinical features are quite variable, many times mimicking characteristics of a pancreatic adenocarcinoma.
Differential diagnosis, treatment and prognosis in pancreatic adenocarcinoma ( pc ) are still a challenge to clinical practice.
The disease was more prevalent in patients with adenocarcinoma, especially pancreatic adenocarcinoma.
Progression of pre-existing pancreatic adenocarcinoma with KRAS mutation.
Use of 2 anti-SPARC antibodies to predict response to chemotherapy for pancreatic adenocarcinoma.
Pan02 mouse pancreatic adenocarcinoma cells were injected into the pancreas of immunocompetent C57BL/6 mice.
Useful also is treatment of breast cancer, pancreatic adenocarcinoma or malignant melanoma.
S2R igands also potentiate conventional anticancer chemotherapies and improve survival in models of pancreatic adenocarcinoma.
Table 1, Dose level reductions for patients with pancreatic adenocarcinoma Dose level.
Chronic Pancreatitis, Suffering from chronic pancreatitis for several decades increases the risk of pancreatic adenocarcinoma.
Table 11, Efficacy results from randomized study in patients with pancreatic adenocarcinoma Intent-to-treat population.
Progression of a type of pre-existing cancers with RAS mutations Chronic Myelomonocytic Leukaemia, Pancreatic adenocarcinoma.
In some examples, a miR gene product that is uniquely associated with pancreatic adenocarcinoma is evaluated.
Table 3, Dose modifications for other adverse drug reactions in patients with pancreatic adenocarcinoma.
This would be a key element of resistance to chemotherapy, mainly in pancreatic adenocarcinoma ( pancreatic cancer ).
A compound for use according to claim 11, in a method of treatment of, pancreatic adenocarcinoma.
Immunohistochemical staining by mAb W9 of a surgically removed human pancreatic adenocarcinoma lesion.
Top 69 aberrantly expressed miRNA precursors in pancreatic adenocarcinoma.
A composition according to any one of claim 1 to 8, wherein the pancreatic cancer is pancreatic adenocarcinoma.
Table 8, Haematologic laboratory-detected abnormalities in pancreatic adenocarcinoma trial.
Table 1, Dose level reductions for patients with pancreatic adenocarcinoma.
PanNETs = = = The genes often found mutated in PanNETs are different from those in pancreatic adenocarcinoma.
Levels of soluble BAG-3 in será of cancer patients Pancreatic adenocarcinoma.
A 68-year-old male patient with diagnosis of pancreatic adenocarcinoma.
Panel A ( 400X ) depicts the hematoxylin and eosin analysis of a pancreatic adenocarcinoma.
You'll also be interested in:
Examples of using Adenocarcinoma
Show more
The incidence of lung adenocarcinoma continues to rise
Adenocarcinoma is the most common histological type
The incidence of lung adenocarcinoma continue to rise
Examples of using Pancreatic
Show more
We have a pancreatic tumor with our name on it
The survival rates for pancreatic cancer
Pancreatic cancer is so deadly because it is difficult to diagnose
